Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers
Clinical trial NCT01888497 · COMPLETED
Trial details
- NCT number
- NCT01888497
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-29
- Primary completion
- 2013-12-14
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.